The company develops high-performance nanocompositve additives and masterbatches. The company provides the entire production chain from a single source, with activities ranging from research and product development to large-scale industrial manufacturing.
Useful applications for The company 's high performance additives can be found in the textile, plastics, coatings, cosmetic and medical sectors. The main product is antimicrobial nanosilver AGS-20 which comes as a powder, coating, textile finish or masterbatch - serving virtually all customers' needs regardless of application.
Hospital-related bacterial infections, so called Nosocomial, are estimated to be the fifth-leading cause of death in the United States. The US Center for Disease Control estimates that nosocomial infections cost hospitals about $4.8 billion annually in extended care and treatment. Nosocomial infections are common with estimates at about 10% of American hospital patients, or more than 2 million cases annually. Death rates in the US alone are estimated to be as high as 88,000 deaths annually. A great majority of healthcare-acquired infections involve many of the pathogens displaying antimicrobial resistance against antibiotics. Silver is effective across a broad range of bacteria and against mutating pathogens. It is also effective in blocking fungi and yeasts known to cause disease. While silver alone does not eliminate infection-associated complications, it may reduce the risk of such occurrences and can be a useful part in an overall strategy for hygiene management.
Silver is known to be harmless to the human body at bacterial effective levels and is, for the most part, non-toxic and does not encounter the problem of microbial cross-resistance. In order to exhibit antimicrobial effects, silver must be present in the ionic state. Nanotechnology provides an effective platform to maximize the antimicrobial capability of silver. Because of the tiny size, each particle in a nanostructure provides a high surface area which allows for an effective release of silver ions and low concentrations. The company ’s nanocomposite technology uses a firmly embedded reservoir system of metallic silver. The silver ion release is tailored to provide antimicrobial activity in a controlled way enabling a long-lasting antimicrobial effect.
